-- Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that Auvi-Q™ (epinephrine injection, USP) is now available in U.S. retail pharmacies nationwide with a prescription from a healthcare provider.
19 Jan 2017 Auvi-Q Auto-injector is approved to treat life-threatening allergic reactions, including anaphylaxis, in patients who are at risk for or have a history of serious allergic reactions. The epinephrine auto-injector features voice instructions that guide the user with step-by-step instructions through the delivery
6 Feb 2013 Sanofi has launched a voice-guided epinephrine auto-injector Auvi-Q in the US to provide emergency treatment for life-threatening allergic reactions in people who are at risk for, or have a history of, anaphylaxis. The first-of-its-kind device is the size and shape of a credit card and the thickness of a smart
Allerject® is indicated for the emergency treatment of serious allergic reactions (anaphylaxis) and is intended for people who are at risk and for people with a history of serious allergic reactions (anaphylaxis). Allerject® should be used immediately to treat yourself or your child when experiencing a severe allergic reaction.
13 Aug 2012
13 Aug 2012 August 13, 2012 — The first voice-guided epinephrine auto-injector (Auvi-Q, sanofi US) has been approved for use by the US Food and Drug Administration (FDA). According to the manufacturer, this is the first auto-injector device with both audio and visual cues to guide patients through the injection
15 Aug 2012 The FDA has approved a new, voice guided epinephrine auto-injector for emergency use to counter the effects of anaphylaxis.
13 Aug 2012 Sanofi just announced receiving FDA clearance for the Auvi-Q epinephrine injector that provides step-by-step voice guidance on how to use it if you're havi.

Annons

The photo has no tags

February 2018